P. Geng

发表

Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59

D. Dai, G. Hu, Chuan-bao Li, 2015, Drug Metabolism and Disposition.

Functional characterization of the defective CYP2C9 variant CYP2C9*18

Jiefu Yang, D. Dai, Jian-Ping Cai, 2021, Pharmacology research & perspectives.

Intracellular GSH and ROS levels may be related to galactose-mediated human lens epithelial cell apoptosis: role of recombinant hirudin variant III.

Y. Ou, P. Geng, Wu-tong Wu, 2009, Chemico-biological interactions.

The Effect of Apigenin on Pharmacokinetics of Imatinib and Its Metabolite N-Desmethyl Imatinib in Rats

Mengchun Chen, G. Hu, Meng-ming Xia, 2013, BioMed research international.

Microsoft Word-2957313-file00.docx

D. Dai, G. Hu, Chuan-bao Li, 2015 .

Characterization of a novel CYP2C9 mutation (1009C>A) detected in a warfarin-sensitive patient.

D. Dai, G. Hu, Zhe-li Jiang, 2014, Journal of pharmacological sciences.

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population

Jie Yang, D. Dai, Quan Zhou, 2022, Frontiers in Pharmacology.

Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo

Ji-hua Shi, D. Dai, Shuang-hu Wang, 2022, Drug design, development and therapy.

In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population

D. Dai, G. Hu, Jian-Ping Cai, 2015, Basic & clinical pharmacology & toxicology.

In vitro functional characterization of 37 CYP2C9 allelic isoforms found in Chinese Han population

D. Dai, G. Hu, Jian-Ping Cai, 2013, Acta Pharmacologica Sinica.

Naringenin has an inhibitory effect on rivaroxaban in rats both in vitro and in vivo

Jiefu Yang, D. Dai, Quan Zhou, 2021, Pharmacology Research & Perspectives.

Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo

D. Dai, Shuang-hu Wang, P. Geng, 2023, Pharmaceutical biology.

Effect of 36 CYP2C9 variants found in the Chinese population on losartan metabolism in vitro

D. Dai, G. Hu, Jian-Ping Cai, 2014, Xenobiotica; the fate of foreign compounds in biological systems.

In Vitro Assessment of 36 CYP2C9 Allelic Isoforms Found in the Chinese Population on the Metabolism of Glimepiride

D. Dai, G. Hu, Jian-Ping Cai, 2014, Basic & clinical pharmacology & toxicology.

Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro

D. Dai, G. Hu, Shuang-hu Wang, 2016, Basic & clinical pharmacology & toxicology.

Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro

D. Dai, Shuang-hu Wang, P. Geng, 2023, Frontiers in Pharmacology.

An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62.

Jiefu Yang, D. Dai, Jian-Ping Cai, 2020, Chemico-biological interactions.

Identification and characterization of a novel CYP2C9 allelic variant in a warfarin-sensitive patient.

D. Dai, G. Hu, Jian-Ping Cai, 2015, Pharmacogenomics.

In vitro functional analysis of 24 novel CYP2C19 variants recently found in the Chinese Han population

D. Dai, G. Hu, Jian-Ping Cai, 2015, Xenobiotica; the fate of foreign compounds in biological systems.

Identification and Functional Assessment of Eight CYP3A4 Allelic Variants *39–*46 Detected in the Chinese Han Population

D. Dai, Shuang-hu Wang, P. Geng, 2024, Drug Metabolism and Disposition.